ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
GSK transfers rights to Ebola vaccines development to US institute
August 08, 2019Drug manufacturer GlaxoSmithKline (GSK) transfers its rights to advance the development of the deadly Ebola Zaire, Ebola Sudan and Marburg virus vaccines to the Sabin Vaccine Institute in the US. -
Ebola vaccines from GSK, Merck elicit yearlong response, study finds
October 16, 2017After initially setting out to test two vaccines on 28,000 volunteers during West Africa's deadly Ebola epidemic, a U.S.-Liberia research team had to dramatically reduce its aspirations when the outbreak started coming to an end. -
Ebola vaccines in a trial elicit immune response for a year long
October 16, 2017Clinical trial results show that two candidate Ebola vaccines can elicit immune responses after initial vaccination that last for at least one year…
Pharma Sources Insight January 2025
